Streetbeat News

Stock Prices

JWN

Nordstrom Inc (NASDAQ:JWN) reported Q3 financial results with revenue of $3.32 billion, down from $3.55 billion YOY. Earnings improved to 25 cents per share from 20 cents. Nordstrom Rack sales decreased by 1.8%, while active, beauty, and accessories categories saw growth. CEO Erik Nordstrom highlighted progress in gross margin and earnings despite economic uncertainty. The company forecasts a 4-6% revenue decline for full-year 2023 and adjusted earnings of $1.90 to $2.10 per share. Telsey Advisory Group analyst Dana Telsey maintained a Market Perform rating but lowered the price target from $19 to $17. Nordstrom shares dropped 0.54% to $14.82 following the report.

Portfolio Pulse from Adam Eckert

November 22, 2023 | 2:10 pm

BTI

British American Tobacco (NYSE:BTI) is facing industry changes with strategic adaptations. Despite a 21.36% stock decline YTD, BTI shows resilience with investments in 'new categories' like vaping, which contribute to 26% revenue growth. The company's financials are stable, with equity holdings exceeding long-term debt. Investors are considering if the stock drop is a buying opportunity, reflecting a Warren Buffett-style value investment with a 9% yield.

Portfolio Pulse from Surbhi Jain

November 22, 2023 | 2:10 pm

AAPL

AMD

ARM

LULU

MSFT

NET

NVDA

QQQ

TSLA

Swaggy Stocks has released data on the top 10 trending stocks on WallStreetBets as of November 22, 2023. The list includes prominent technology and consumer companies that are frequently discussed on the popular subreddit. The companies mentioned are NVIDIA (NVDA), C3.ai (AI), Invesco QQQ Trust (QQQ), Microsoft (MSFT), Cloudflare (NET), Tesla (TSLA), Apple (AAPL), Advanced Micro Devices (AMD), Lululemon Athletica (LULU), and Arm Holdings (ARM).

Portfolio Pulse from Benzinga Newsdesk

November 22, 2023 | 2:07 pm

IPA

ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) announced the launch of BioStrand's advanced AI-driven drug discovery platform, integrating diverse data modalities with proprietary HYFT technology and LENSai platform. The platform aims to enhance accuracy and interpretability in drug development, leveraging Vertical AI for tailored therapies. The market for AI in healthcare is expected to grow significantly, positioning ImmunoPrecise and BioStrand as potential leaders in AI-driven biotherapeutic research.

Portfolio Pulse from Benzinga Newsdesk

November 22, 2023 | 2:06 pm

ATPC

AGAPE ATP Corporation (NASDAQ:ATPC) has announced a share repurchase plan to buy back up to $1 million of its shares over the next 6 months. The repurchases will be conducted in the open market or through private transactions, and will be funded from existing funds. The plan does not obligate ATPC to purchase any specific number of shares and can be adjusted, suspended, or discontinued at any time.

Portfolio Pulse from Benzinga Newsdesk

November 22, 2023 | 2:05 pm

DKS

Morgan Stanley analyst Simeon Gutman has maintained an Overweight rating on Dick's Sporting Goods (NYSE:DKS) and increased the price target from $145 to $150.

Portfolio Pulse from Benzinga Newsdesk

November 22, 2023 | 2:01 pm

VIRT

Analysts have provided ratings for Virtu Financial (NASDAQ:VIRT) with 1 bullish, 1 somewhat bullish, and 2 indifferent ratings in the last quarter. The average price target is $20.75, representing an upside from the current price of $17.54. This target has decreased by 7.08% from the previous target of $22.33. Analyst ratings are opinions on stock performance and are updated quarterly.

Portfolio Pulse from Benzinga Insights

November 22, 2023 | 2:00 pm

NURO

NeuroMetrix shares have resumed trading. There is no additional context provided in the article regarding the reason for the halt or the implications of the resumption.

Portfolio Pulse from Benzinga Newsdesk

November 22, 2023 | 2:00 pm

LLY

Over the past 10 years, Eli Lilly (NYSE:LLY) has produced an average annual return of 27.97%, outperforming the market by 18.31% on an annualized basis. A $1000 investment in LLY a decade ago would be worth $11,599.14 today. Eli Lilly currently has a market capitalization of $565.31 billion. The article highlights the significant impact of compounded returns on investment growth over time.

Portfolio Pulse from Benzinga Insights

November 22, 2023 | 2:00 pm

CCEP

Coca-Cola Europacific (NASDAQ:CCEP) has delivered an average annual return of 13.43% over the past 15 years, outperforming the market by 2.04% annually. With a current market cap of $27.91 billion, a $1000 investment in CCEP 15 years ago would be worth $6,886.75 today. The article highlights the impact of compounded returns on investment growth over time.

Portfolio Pulse from Benzinga Insights

November 22, 2023 | 2:00 pm